CCP
VCYT icon

Clough Capital Partners’s Veracyte VCYT Stock Holding History

Clough Capital Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-115,400
Closed -$6.2M – 166
2021
Q1 		$6.2M Buy
+115,400
New +$6.65M 0.28% 75

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Clough Capital Partners's VCYT Position: Q3 2023 in Review

Clough Capital Partners sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 276,260 shares — an estimated $7.04M sold.

Clough Capital Partners first reported a position in VCYT in Q4 2013 and held it in 31 quarters. The position peaked at $16M in Q2 2015. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

  • Clough Capital Partners reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
  • Clough Capital Partners sold 276,260 Veracyte shares in Q3 2023, an estimated $7.04M.
  • Clough Capital Partners first reported a position in Veracyte in Q4 2013 and held it in 31 quarters.
  • Clough Capital Partners's Veracyte position peaked at $16M in Q2 2015.
  • 236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on Clough Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.